Navigation Links
Solutia Reports Third Quarter 2009 Results
Date:10/26/2009

(30) (31) Other reorganization and emergence related payments --- --- (17) ---- Cash Used in Reorganization Activities -- (30) (348) --- ---- ----- Cash Provided by (Used in) Operations - Continuing Operations 123 95 (364) Cash Provided by (Used in) Operations - Discontinued Operations 58 (122) (48) --- ----- ---- Cash Provided by (Used in) Operations 181 (27) (412) --- ---- ----- INVESTING ACTIVITIES: Property, plant and equipment purchases (27) (52) (15) Acquisition and investment payments (2) (2) -- Investment proceeds and property disposals 3 53 -- --- --- --- Cash Used in Investing Activities - Continuing Operations (26) (1) (15) Cash Provided by (Used in) Investing Activities - Discontinued Operations 16 (27) (14) --- ---- ---- Cash Used in Investing Activities (10) (28) (29) ---- ---- ---- FINANCING ACTIVITIES: Net change in lines of credit (13) 28 -- Proceeds from long-term debt obligations
'/>"/>
SOURCE Solutia Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Solutia Reports First Quarter 2009 Results
2. Solutia to Present at Deutsche Bank Small and Mid Cap Conference
3. Hanger Orthopedic Group, Inc. Reports an Increase of 30.4% in Earnings Per Share, to $0.30, for the Third Quarter 2009 and Raises Its 2009 Guidance
4. NuVasive Reports Third Quarter 2009 Financial Results
5. Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH)
6. Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles
7. Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist
8. Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial
9. Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
10. Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues
11. Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... PHILADELPHIA, Dec. 15 The Center ... Advanstar Communications, is pleased to announce the ... Pharmaceutical/Biotech Accounting and Reporting Congress . The ... Philadelphia, on March 16-17, 2010. ,, Over ... professionals have attended this premier event since ...
(Date:12/15/2009)... December 15 , ... to Evaluate the Ability of,Cardiopoietic Cells to Restore ... BioSciences, a leading Belgian biotechnology company specialising,in cell-based ... that it has completed, two months ahead of ... Phase II/III trial of C-Cure, a,unique stem cell ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
(Date:12/14/2009)... -- The third edition of Infusion ... published by the Infusion Nurses Society (INS), includes ... Anthracyclines are a group of chemotherapy medications ... been used in the treatment of various types ... ,, According to the INS publication: "In September ...
Breaking Biology Technology:CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... SAN DIEGO, May 19 Sangart, Inc., a ... and,commercialization of therapeutic oxygen transport agents today announced,that ... III trial of its lead,product, Hemospan(R)., Sangart ... to be available in,the second half of 2008., ...
... deliver first open source infectious disease ... management system to meet CDC mandate, PORTLAND, ... brings like-minded organizations,together to work on collaborative software at a ... open source, web-based infectious,disease reporting and management system., The ...
... Medical Technology Distributors ... in 2007., PLEASANTON, Calif., May 19 Direct ... a distribution network covering all,of Russia. This partnership has ... and volume sales to a number of medical,providers in ...
Other Biology Technology:Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent 2Collaborative Software Initiative Addresses State Governments' Requirements for Meeting Infectious Disease Compliance 2Collaborative Software Initiative Addresses State Governments' Requirements for Meeting Infectious Disease Compliance 3Collaborative Software Initiative Addresses State Governments' Requirements for Meeting Infectious Disease Compliance 4Direct Medical Systems Reaches Profitability in 2-1/2 Years, as a Result of Sales of the World's Smallest and Lightest Ultrasound System, the InNovaSound USB Ultrasound. 2
(Date:12/15/2009)... Economics, environmental impacts, social dynamics, and production levels ... success of an agroecosystem. Positive or negative, these ... and social groups to continuously adapt farming and ... Experiential learning theory suggests that knowledge is gained ... lessons are especially valuable for environmental and agricultural ...
(Date:12/15/2009)... and ancient American horses may have been grazing ... longer than previously thought. After plucking ancient DNA ... of researchers used cutting-edge techniques to uncover "genetic ... dated to between 7,600 and 10,500 calendar years. ... population of these now-extinct mammals endured longer in ...
(Date:12/15/2009)... This release is available in German ... use in predicting the future distribution of mammals. This ... niches of 140 indigenous European mammals. The researchers analysed ... as well as the phylogenetic information of the species. ... for closely related species, mammals seem to adapt fast ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Species distribution models are of only limited value for predicting future mammal distributions 2Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 1Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 2Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 3Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 4Blanchette Rockefeller Neurosciences Institute to Collaborate with Top Brain Injury Group 55972 1Blanchette Rockefeller Neurosciences Institute to Collaborate with Top Brain Injury Group 55972 2Blanchette Rockefeller Neurosciences Institute to Collaborate with Top Brain Injury Group 55972 3Renowned Grief Recovery Experts Now Blogging on Psychology Today 55967 1Renowned Grief Recovery Experts Now Blogging on Psychology Today 55967 2
... new variant of the bird flu virus H5N1 emerged in ... a large part of southern China, despite an ongoing program ... Hong Kong in collaboration with scientists at St. Jude Children's ... to be responsible for the increased occurrence of H5N1 poultry ...
... In the first large-scale analysis of proteins in the ... novel proteins and mechanisms that may one day lead ... results, reported in the current issue of Molecular Psychiatry, ... 50 proteins and point to profound changes in brain ...
... an animal's immune response to the 1918 influenza virus ... supported scientists in an article appearing online today in ... that the 1918 virus triggers a hyperactive immune response ... Furthermore, their results suggest that it is the ...
Other Biology News:Control measures fail to stop spread of new H5N1 virus 2High-tech research shows cocaine changes proteins and brain function 2Mouse study reveals new clues about virulence of 1918 influenza virus 2Mouse study reveals new clues about virulence of 1918 influenza virus 3